Age at surgical menopause influences cognitive decline and Alzheimer pathology in older women

Neurology

Volumn 82, Issue 3, 2014, Pages 222-229

  Bove, Riley ^a   Secor, Elizabeth ^a   Chibnik, Lori B ^a   Barnes, Lisa L ^a,b   Schneider, Julie A ^b   Bennett, David A ^b   De Jager, Philip L ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; COGNITION; COHORT ANALYSIS; DISEASE ASSOCIATION; EARLY MENOPAUSE; EDUCATIONAL STATUS; EPISODIC MEMORY; FEMALE; GYNECOLOGIC SURGERY; HORMONE SUBSTITUTION; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MENOPAUSE; MENTAL DETERIORATION; MIDDLE AGED; NEUROPATHOLOGY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SECONDARY ANALYSIS; SEMANTIC MEMORY; SENESCENCE; SENILE PLAQUE; SMOKING HABIT; VERY ELDERLY; WOMEN'S HEALTH; AGE; AGING; COGNITION DISORDERS; DRUG EFFECTS; HEALTH SURVEY; MEMORY DISORDERS; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PLAQUE, AMYLOID; SINGLE BLIND PROCEDURE; TREATMENT OUTCOME; UTILIZATION;

AGE FACTORS; AGED; AGED, 80 AND OVER; AGING; ALZHEIMER DISEASE; COGNITION DISORDERS; FEMALE; HEALTH SURVEYS; HORMONE REPLACEMENT THERAPY; HUMANS; LONGITUDINAL STUDIES; MEMORY DISORDERS; MEMORY, EPISODIC; MENOPAUSE; MIDDLE AGED; PLAQUE, AMYLOID; SINGLE-BLIND METHOD; TREATMENT OUTCOME;

EID: 84895768182     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000000033     Document Type: Article

References (40)

1. Hurd MD, Martorell P, Delavande A, Mullen KJ, Langa KM. Monetary costs of dementia in the United States. N Engl J Med 2013;368:1326-1334.
2. Barron AM, Pike CJ. Sex hormones, aging, and Alzheimer's disease. Front Biosci 2012;4:976-997.
3. Boulware MI, Kent BA, Frick KM. The impact of age-related ovarian hormone loss on cognitive and neural function. Curr Top Behav Neurosci 2012;10:165-184.
4. Spence RD, Hamby ME, Umeda E, et al. Neuroprotection mediated through estrogen receptor-alpha in astrocytes. Proc Natl Acad Sci USA 2011;108:8867-8872.
5. Coppus AM, Evenhuis HM, Verberne GJ, et al. Early age at menopause is associated with increased risk of dementia and mortality in women with Down syndrome. J Alzheimers Dis 2010;19:545-550.
6. Corbo RM, Gambina G, Broggio E, Scacchi R. Influence of variation in the Follicle-Stimulating Hormone Receptor Gene (FSHR) and age at menopause on the development of Alzheimer's disease in women. Dement Geriatr Cogn Disord 2011;32:63-69.
7. Rocca WA, Bower JH, Maraganore DM, et al. Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause. Neurology 2007;69:1074-1083.
8. Phung TK, Waltoft BL, Laursen TM, et al. Hysterectomy, oophorectomy and risk of dementia: A nationwide historical cohort study. Dement Geriatr Cogn Disord 2010;30:43-50.
9. Zhou G, Liu J, Sun F, Duan L, Yan B, Peng Q. Cognitive functioning in elderly women who underwent unilateral oophorectomy before menopause. Int J Neurosci 2011; 121:196-200.
10. Geerlings MI, Ruitenberg A, Witteman JC, et al. Reproductive period and risk of dementia in postmenopausal women. JAMA 2001;285:1475-1481.
11. Barnes LL, Wilson RS, Schneider JA, Bienias JL, Evans DA, Bennett DA. Gender, cognitive decline, and risk of AD in older persons. Neurology 2003;60:1777-1781.
12. Rocca WA, Grossardt BR, Shuster LT. Oophorectomy, menopause, estrogen treatment, and cognitive aging: Clinical evidence for a window of opportunity. Brain Res 2011; 1379:188-198.
13. Vearncombe KJ, Pachana NA. Is cognitive functioning detrimentally affected after early, induced menopause? Menopause 2009;16:188-198.
14. Henderson VW, Sherwin BB. Surgical versus natural menopause: Cognitive issues. Menopause 2007;14:572-579.
15. Bennett DA, Schneider JA, Arvanitakis Z, et al. Neuropathology of older persons without cognitive impairment from two community-based studies. Neurology 2006;66: 1837-1844.
16. Bennett DA, Schneider JA, Buchman AS, et al. The rush memory and aging project: Study design and baseline characteristics of the study cohort. Neuroepidemiology 2005; 25:163-175.
17. Bennett DA, Schneider JA, Arvanitakis Z, Wilson RS. Overview and findings from the religious orders study. Curr Alzheimer Res 2012;9:628-645.
18. Bennett DA, Schneider JA, Buchman AS, Barnes LL, Boyle PA, Wilson RS. Overview and findings from the rush memory and aging project. Curr Alzheimer Res 2012;9:646-663.
19. Wilson RS, Schneider JA, Boyle PA, Arnold SE, Tang Y, Bennett DA. Chronic distress and incidence of mild cognitive impairment. Neurology 2007;68:2085-2092.
20. Bennett DA, Wilson RS, Boyle PA, Buchman AS, Schneider JA. Relation of neuropathology to cognition in persons without cognitive impairment. Ann Neurol 2012; 72:599-609.
21. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state": A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
22. Wilson RS, Beckett LA, Barnes LL, et al. Individual differences in rates of change in cognitive abilities of older persons. Psychol Aging 2002;17:179-193.
23. Bennett DA, Wilson RS, Schneider JA, et al. Natural history of mild cognitive impairment in older persons. Neurology 2002;59:198-205.
24. Wilson RS, Mendes De Leon CF, Barnes LL, et al. Participation in cognitively stimulating activities and risk of incident Alzheimer disease. JAMA 2002;287:742-748.
25. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
26. Bennett DA, Schneider JA, Aggarwal NT, et al. Decision rules guiding the clinical diagnosis of Alzheimer's disease in two community-based cohort studies compared to standard practice in a clinic-based cohort study. Neuroepidemiology 2006;27:169-176.
27. Bennett DA, Schneider JA, Bienias JL, Evans DA, Wilson RS. Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions. Neurology 2005;64:834-841.
28. Schneider JA, Wilson RS, Bienias JL, Evans DA, Bennett DA. Cerebral infarctions and the likelihood of dementia from Alzheimer disease pathology. Neurology 2004;62:1148-1155.
29. The National Institute on Aging, and Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer's disease. Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. Neurobiol Aging 1997;18:S1-S2.
30. Shao H, Breitner JC, Whitmer RA, et al. Hormone therapy and Alzheimer disease dementia: New findings from the Cache County Study. Neurology 2012;79:1846-1852.
31. Bennett DA, Wilson RS, Schneider JA, et al. Apolipoprotein E epsilon4 allele, AD pathology, and the clinical expression of Alzheimer's disease. Neurology 2003;60: 246-252.
32. Rapp SR, Espeland MA, Shumaker SA, et al. Effect of estrogen plus progestin on global cognitive function in postmenopausal women: The Women's Health Initiative Memory Study: A randomized controlled trial. JAMA 2003; 289:2663-2672.
33. McLay RN, Maki PM, Lyketsos CG. Nulliparity and late menopause are associated with decreased cognitive decline. J Neuropsychiatry Clin Neurosci 2003;15:161-167.
34. Hogervorst E, Kusdhany LS, Ismail RI, et al. Age at natural menopause and memory function: Modification by education and genotype. Endocrinol Metab Syndr 2011;S7:1-7.
35. Hong X, Zhang X, Li H. A case-control study of endogenous estrogen and risk of Alzheimer's disease [in Chinese]. Zhonghua Liu Xing Bing Xue Za Zhi 2001;22:379-382.
36. Henderson VW. Alzheimer's disease and other neurological disorders. Climacteric 2007;10(suppl 2):92-96.
37. Barrett-Connor E, Laughlin GA. Endogenous and exogenous estrogen, cognitive function, and dementia in postmenopausal women: Evidence from epidemiologic studies and clinical trials. Semin Reprod Med 2009;27:275-282.
38. Craig MC, Maki PM, Murphy DG. The Women's Health Initiative Memory Study: Findings and implications for treatment. Lancet Neurol 2005;4:190-194.
39. Howe HL. Age-specific hysterectomy and oophorectomy prevalence rates and the risks for cancer of the reproductive system. Am J Public Health 1984;74:560-563.
40. den Tonkelaar I. Validity and reproducibility of selfreported age at menopause in women participating in the DOM-project. Maturitas 1997;27:117-123.